INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $630,000 | +23.8% | 136,167 | -6.3% | 0.00% | – |
| Q4 2018 | $509,000 | -66.7% | 145,327 | -4.2% | 0.00% | -100.0% |
| Q3 2018 | $1,530,000 | +67.2% | 151,756 | +20.1% | 0.00% | 0.0% |
| Q2 2018 | $915,000 | +60.2% | 126,335 | +33.7% | 0.00% | – |
| Q1 2018 | $571,000 | -35.2% | 94,495 | +3.2% | 0.00% | -100.0% |
| Q4 2017 | $881,000 | -5.4% | 91,570 | -12.6% | 0.00% | 0.0% |
| Q3 2017 | $931,000 | -8.0% | 104,812 | +31.1% | 0.00% | 0.0% |
| Q2 2017 | $1,012,000 | +21.1% | 79,943 | +0.6% | 0.00% | 0.0% |
| Q1 2017 | $836,000 | +20.8% | 79,468 | +5.7% | 0.00% | 0.0% |
| Q4 2016 | $692,000 | -17.8% | 75,193 | +5.4% | 0.00% | 0.0% |
| Q3 2016 | $842,000 | -14.5% | 71,343 | -6.3% | 0.00% | 0.0% |
| Q2 2016 | $985,000 | -64.7% | 76,119 | -56.3% | 0.00% | -75.0% |
| Q1 2016 | $2,787,000 | -43.6% | 174,248 | +0.9% | 0.00% | -42.9% |
| Q4 2015 | $4,944,000 | +129.2% | 172,670 | +127.9% | 0.01% | +133.3% |
| Q3 2015 | $2,157,000 | -0.6% | 75,770 | +25.5% | 0.00% | 0.0% |
| Q2 2015 | $2,170,000 | +37.3% | 60,389 | +122.1% | 0.00% | +50.0% |
| Q1 2015 | $1,581,000 | +60.3% | 27,189 | +16.3% | 0.00% | +100.0% |
| Q4 2014 | $986,000 | +11.5% | 23,382 | +2.7% | 0.00% | 0.0% |
| Q3 2014 | $884,000 | +92.2% | 22,772 | +54.9% | 0.00% | 0.0% |
| Q2 2014 | $460,000 | -65.4% | 14,700 | -54.2% | 0.00% | -50.0% |
| Q1 2014 | $1,331,000 | +377.1% | 32,115 | +346.0% | 0.00% | +100.0% |
| Q4 2013 | $279,000 | +6.1% | 7,200 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $263,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |